Richard Burr: “Where we are in terms of timeliness is not acceptable.”

I went through a litany in my opening statements of the deficiencies in what FDA committed to and what they missed.

More than 278 therapies have been approved under the accelerated approval pathway over the 30 year history, saving and improving thousands of lives.

I oppose Ms. Kotagal's nomination and urge my colleagues to do the same.

There is no Member that has defended the FDA more than this one and there is no Member in Congress that has tried to fix areas when they are broken than this one.